The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

These might include: tummy pain unexplained weight loss loss of appetite indigestion (dyspepsia) yellowing of the skin and whites of the eyes (jaundice) These symptoms could be due to a pancreatic ...

A consensus statement published in Endocrine Practice examines how health care professionals should approach treating and ...

Neuroendocrine tumors (NETs) are rare ... NETs can be difficult to diagnosis as symptoms can mimic other diseases. Symptoms can include abdominal pain, flushing, diarrhea, heart palpitations ...

Increasing Incidence of Neuroendocrine Tumors: Globally rising cases demand effective treatment ... Complexity in Diagnosis: Non-specific symptoms lead to diagnostic challenges, affecting treatment ...

Appointments might be more often than this if you: have a fast growing cancer. can't have surgery are having treatment to control your symptoms rather than to cure your neuroendocrine cancer Contact ...

will continue to be main therapies for functioning neuroendocrine tumors over the next years. Pasireotide, a new panreceptor analog, might control clinical symptoms and hormone release in patients ...

Having turned professional in 1995, Paul Hunter started to take snooker by storm in the early 2000s, winning three Masters ...

Paul Hunter was one snooker's brightest talents yet he sadly died at just 27-years-old after being diagnosed with a condition ...

The incidence of pancreatic adenocarcinoma increases across all age groups, whereas colorectal adenocarcinoma increases only among younger age groups.